171 related articles for article (PubMed ID: 36641680)
1. Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly.
Igarashi A; Sakata Y; Azuma-Kasai M; Kamiyama H; Kawaguchi M; Tomita K; Ishii M; Ikeda M
J Alzheimers Dis; 2023; 91(4):1447-1458. PubMed ID: 36641680
[TBL] [Abstract][Full Text] [Related]
2. Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis.
Lin J; Wong CKH; Cheung JPY; Cheung PWH; Luo N
Eur J Health Econ; 2022 Nov; 23(8):1383-1395. PubMed ID: 35122171
[TBL] [Abstract][Full Text] [Related]
3. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
4. Translation, validity and reliability of the British Sign Language (BSL) version of the EQ-5D-5L.
Rogers KD; Pilling M; Davies L; Belk R; Nassimi-Green C; Young A
Qual Life Res; 2016 Jul; 25(7):1825-34. PubMed ID: 26887955
[TBL] [Abstract][Full Text] [Related]
5. Measurement properties of the EQ-5D-5L compared to EQ-5D-3L in the Thai diabetes patients.
Pattanaphesaj J; Thavorncharoensap M
Health Qual Life Outcomes; 2015 Feb; 13():14. PubMed ID: 25890017
[TBL] [Abstract][Full Text] [Related]
6. The added value of extending the EQ-5D-5L with an itching item for the assessment of health-related quality of life of burn patients: an explorative study.
Spronk I; Bonsel GJ; Polinder S; van Baar ME; Janssen MF; Haagsma JA
Burns; 2021 Jun; 47(4):873-879. PubMed ID: 33012569
[TBL] [Abstract][Full Text] [Related]
7. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
8. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
[TBL] [Abstract][Full Text] [Related]
9. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
10. Does the EQ-5D-5L benefit from extension with a cognitive domain: Testing a multi-criteria psychometric strategy in trauma patients.
Geraerds AJLM; Bonsel GJ; Polinder S; Panneman MJM; Janssen MF; Haagsma JA
Qual Life Res; 2020 Sep; 29(9):2541-2551. PubMed ID: 32277337
[TBL] [Abstract][Full Text] [Related]
11. Testing the Psychometric Properties of 9 Bolt-Ons for the EQ-5D-5L in a General Population Sample.
Rencz F; Janssen MF
Value Health; 2024 Jul; 27(7):943-954. PubMed ID: 38599517
[TBL] [Abstract][Full Text] [Related]
12. An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care.
Ratcliffe J; Flint T; Easton T; Killington M; Cameron I; Davies O; Whitehead C; Kurrle S; Miller M; Liu E; Crotty M
Appl Health Econ Health Policy; 2017 Jun; 15(3):399-412. PubMed ID: 27882528
[TBL] [Abstract][Full Text] [Related]
13. Examining the psychometric properties of a split version of the EQ-5D-5L anxiety/depression dimension in patients with anxiety and/or depression.
Belay YB; Mihalopoulos C; Lee YY; Mulhern B; Engel L
Qual Life Res; 2023 Jul; 32(7):2025-2036. PubMed ID: 36809437
[TBL] [Abstract][Full Text] [Related]
14. Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy.
Xu RH; Dai Y; Ng SSM; Tsang HWH; Zhang S; Dong D
Eur J Health Econ; 2024 Feb; 25(1):103-115. PubMed ID: 36809586
[TBL] [Abstract][Full Text] [Related]
15. Association between locomotive syndrome and the Japanese version of the EQ-5D-5L in middle-aged and elderly people in Japan.
Tanaka S; Ando K; Kobayashi K; Seki T; Hamada T; Machino M; Ota K; Morozumi M; Kanbara S; Ito S; Ishiguro N; Hasegawa Y; Imagama S
Nagoya J Med Sci; 2020 Feb; 82(1):5-14. PubMed ID: 32273627
[TBL] [Abstract][Full Text] [Related]
16. Reliability of the quality of life-aged care consumers (QOL-ACC) and EQ-5D-5L among older people using aged care services at home.
Khadka J; Milte R; Hutchinson C; Cleland J; Ratcliffe J
Health Qual Life Outcomes; 2024 May; 22(1):40. PubMed ID: 38816717
[TBL] [Abstract][Full Text] [Related]
17. Validity of an enhanced EQ-5D-5L measure with an added cognitive dimension in patients with stroke.
de Graaf JA; Kuijpers M; Visser-Meily J; Kappelle LJ; Post M
Clin Rehabil; 2020 Apr; 34(4):545-550. PubMed ID: 32070131
[TBL] [Abstract][Full Text] [Related]
18. Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia.
Campbell JA; Ahmad H; Chen G; van der Mei I; Taylor BV; Claflin S; Henson GJ; Simpson-Yap S; Laslett LL; Hawkes K; Hurst C; Waugh H; Palmer AJ
Qual Life Res; 2023 Feb; 32(2):553-568. PubMed ID: 36036311
[TBL] [Abstract][Full Text] [Related]
19. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.
Michalowsky B; Hoffmann W; Xie F
J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901
[TBL] [Abstract][Full Text] [Related]
20. Responsiveness of the anxiety/depression dimension of the 3- and 5-level versions of the EQ-5D in assessing mental health.
Crick K; Al Sayah F; Ohinmaa A; Johnson JA
Qual Life Res; 2018 Jun; 27(6):1625-1633. PubMed ID: 29516342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]